Search
Type to search all 129 recommendations
SSC 2026 Sepsis Guidelines
Surviving Sepsis Campaign • Critical Care Medicine • April 2026 • 129 Statements
15
Screening & Early Mgmt
Statements 1–15
26
Infection & Antimicrobials
Statements 16–41
23
Hemodynamic Management
Statements 42–64
14
Respiratory Support
Statements 65–78
21
Adjunctive Therapies
Statements 79–99
8
Goals of Care
Statements 100–107
16
Transitions of Care
Statements 108–123
6
Long-term Recovery
Statements 124–129
⇧ Key Changes from SSC 2021
⇧ Beta-lactam infusion → STRONG (BLING III)
NEW: MAP 60–65 for age ≥65 yrs
NEW: Peripheral vasopressors first
NEW: MDR risk stratification
NEW: HFNC preferred over NIV
NEW: Awake proning
NEW: Against antipyretics for outcomes
NEW: SDD in low-AMR ICUs
NEW: Against Vitamin D treatment
NEW: Against beta-blockers in shock
🎙️ Color Guide
Strong Recommendation
"we recommend"
Conditional Recommendation
"we suggest"
Strong Against
"we recommend against"
Conditional Against
"we suggest against"
Good Practice Statement
GPS
Insufficient Evidence
no recommendation
● Green dot = New in 2026 • Tap any card to expand
Screening & Early Management
Statements 1–15 • Tap cards to expand
Infection & Antimicrobials
Statements 16–41 • Includes pharmacy-critical recommendations
Hemodynamic Management
Statements 42–64 • Vasopressor ladder & fluid tables included
Respiratory Support
Statements 65–78
Adjunctive Therapies
Statements 79–99 • Pharmacy-key recommendations included
Goals of Care
Statements 100–107
Transitions of Care
Statements 108–123
Long-term Recovery
Statements 124–129